ZA6-30165-80812 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Dose 1 — Moderna
2021-03-22
Registered in v-safe
2021-03-22
Survey response — 14 day, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Be unable to work

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-22
Report sent to call center — 14 day, dose 1
Be unable to work

1 call case(s)
2021-03-27
Health check-in — 21 day, dose 1
Feeling: Good

Adult check-in
2021-04-03
Dose 2 — Moderna
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Muscle or body aches

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-06
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site rash, Rash erythematous — Feeling: Good · Rash, not including the immediate area around the injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Moderna
2	2021-04-03	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-03-22	priority 2/3

Free text

Release 6

Symptoms: I was diagnosed with a fetal demise on 3/16/21. I was 17 weeks and 4 days with an uncomplicated pregnancy.

Release 7

Systemic reaction (other): I have a red non itchy rash about 4 inches below where I got the injection.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pre-existing disease	✓	✓	✓
SRO	Injection site rash	✓	✓	✓
SRO	Rash erythematous	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release